![Keith A Carlson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith A Carlson
Direktor/Vorstandsmitglied bei Bexion Pharmaceuticals, Inc.
Aktive Positionen von Keith A Carlson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bexion Pharmaceuticals, Inc.
![]() Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Keith A Carlson
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Bexion Pharmaceuticals, Inc.
![]() Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Commercial Services |
- Börse
- Insiders
- Keith A Carlson
- Erfahrung